Kinesiotaping in Isolated Meniscus Injuries

May 4, 2026 updated by: Nurten NAS KIRDAR, Bandırma Onyedi Eylül University

The Effect of Kinesiotaping on Pain and Functionality in Isolated Meniscus Injuries: A Randomized Controlled Study

The effect of kinesiotaping on pain and functionality in isolated meniscus injuries.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Our study was designed as a randomized controlled trial. All patients presenting to the Physical Medicine and Rehabilitation outpatient clinic with knee pain and meeting the inclusion criteria will be included in the study after being informed and giving their consent. Patients' age, gender, and body mass index will be recorded. Patients will be divided into three groups using stratified randomization. An attempt will be made to ensure a homogeneous distribution of patients in terms of gender, age, and body mass index. Group 1 will receive standard treatment, Group 2 will receive standard treatment + kinesiotaping, and Group 3 will receive standard treatment + sham taping. Standard treatment will consist of strengthening exercises for the quadriceps and hamstring muscles, stretching exercises around the knee, proprioceptive exercises, and activity modification. These exercises will be taught to the patient and they will be asked to perform them at home five days a week for three weeks. Kinesiotaping and sham taping will be applied three times, once every five days. Kinesiotaping will be applied to the group with a specific tension and technique (quadriceps facilitation technique, "Y" tape shape, applied with 25-50% tension), while the sham group will have the tape simply applied to the skin without any tension (perpendicular to the quadriceps muscle, tension-free). Kinesiotapes do not contain any medication; their effect depends on the technique (facilitation, inhibition, etc.) and tension level (10%, 25%, 50%, 75%). All patients will have VAS and WOMAC parameters evaluated before treatment, on day 20, and at month 3 after treatment.

Study Type

Interventional

Enrollment (Estimated)

75

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Turkey (Türkiye)
      • Balıkesir, Turkey (Türkiye)
        • Recruiting
        • Bandırma Onyedi Eylul University Faculty of Medicine
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Ages 18-50
  • Knee pain lasting longer than 2 weeks
  • Having a diagnosis of isolated meniscus injury (grade 1, 2 or 3 meniscus degeneration) confirmed by magnetic resonance imaging (MRI)
  • Not having undergone knee surgery in the last 6 months
  • Not having received intraarticular injections in the knee area
  • Being willing to participate in the study

Exclusion Criteria:

  • Trauma history
  • Anterior or posterior cruciate ligament injury
  • Collateral ligament injuries
  • Advanced knee osteoarthritis
  • Rheumatic or neurological disease
  • Allergy or skin condition to kinesiotape
  • History of intraarticular injection
  • Neuromuscular dysfunction
  • Rheumatological disease
  • Cognitive dysfunction

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercises
Standard treatment will consist of strengthening exercises for the quadriceps and hamstring muscles, stretching exercises around the knee, proprioceptive exercises, and activity modification. These exercises will be taught to the patient and they will be asked to perform them at home five days a week for three weeks.
Behavioral: Exercise
rengthening exercises for the quadriceps and hamstring muscles, stretching exercises around the knee, proprioceptive exercises, and activity modification.
Experimental: kinesiotaping
Kinesiotaping will be applied three times, once every five days. Kinesiotaping will be applied to the group with a specific tension and technique (quadriceps facilitation technique, "Y" tape shape, applied with 25-50% tension). Kinesiotapes do not contain any medication; their effect depends on the technique (facilitation, inhibition, etc.) and tension level (10%, 25%, 50%, 75%).
Procedure: kinesiotaping
Kinesiotaping will be applied three times, once every five days. Kinesiotaping will be applied to the group with a specific tension and technique (quadriceps facilitation technique, "Y" tape shape, applied with 25-50% tension). Kinesiotapes do not contain any medication; their effect depends on the technique (facilitation, inhibition, etc.) and tension level (10%, 25%, 50%, 75%).
Experimental: sham taping
Sham taping will be applied three times, once every five days. The sham group will have the tape simply applied to the skin without any tension (perpendicular to the quadriceps muscle, tension-free). Kinesiotapes do not contain any medication; their effect depends on the technique (facilitation, inhibition, etc.) and tension level (10%, 25%, 50%, 75%).
Procedure: sham taping
sham taping will be applied three times, once every five days. the sham group will have the tape simply applied to the skin without any tension (perpendicular to the quadriceps muscle, tension-free). Kinesiotapes do not contain any medication; their effect depends on the technique (facilitation, inhibition, etc.) and tension level (10%, 25%, 50%, 75%).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
VAS
Time Frame: 3 months
The VAS (Visual Analog Scale) will be used to determine the severity of knee pain. The VAS is a reliable and easily applicable scale accepted worldwide in the literature for measuring the severity of pain in patients. The Visual Analog Scale is used to convert values that cannot be measured numerically into numerical values. It is a scale where the starting point is -0- "no pain" and the other end is -10- "very severe pain," with numerical values assigned to each centimeter (cm) in one-centimeter increments.
3 months
WOMAC
Time Frame: 3 months
The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) is a widely used, valid, and reliable index for evaluating patients with osteoarthritis. It is also very commonly used in knee problems other than osteoarthritis to assess knee pain and knee function. It is a recommended metric for osteoarthritis studies by the Outcome Measures in Rheumatology Clinical Trials (OMERACT). The WOMAC OA index, validated and proven reliable in Turkish by Tüzün et al., consists of three sections and 24 questions assessing pain, stiffness, and physical function. The maximum possible scores are 20 for the pain subgroup, 8 for stiffness, and 68 for physical function. Higher scores indicate increased pain and stiffness, and impaired physical function.
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Bandırma Onyedi Eylül University

Investigators

  • Principal Investigator: Nurten NAS KIRDAR, Assistant Professor, Bandırma Onyedi Eylül University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2026

Primary Completion (Estimated)

October 30, 2026

Study Completion (Estimated)

October 30, 2026

Study Registration Dates

First Submitted

April 28, 2026

First Submitted That Met QC Criteria

May 4, 2026

First Posted (Actual)

May 7, 2026

Study Record Updates

Last Update Posted (Actual)

May 7, 2026

Last Update Submitted That Met QC Criteria

May 4, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • E-67961857-050.04-2600014939

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Once our study is completed, if it is deemed suitable for evaluation and publication in a peer-reviewed journal on the subject, all researchers will be able to access our results.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Meniscus Injury

Clinical Trials on Exercise

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe